載入...
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
The T cell co-stimulatory molecule OX40 and its cognate ligand OX40L have attracted broad research interest as a therapeutic target in T cell-mediated diseases. Accumulating preclinical evidence highlights the therapeutic efficacy of both agonist and blockade of the OX40–OX40L interaction. Despite t...
Na minha lista:
| 發表在: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049610/ https://ncbi.nlm.nih.gov/pubmed/32140389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.08.010 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|